Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Kahn, RS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 101 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Schnack, HG; Pol, HEH; Baare, WFC; Viergever, MA; Kahn, RS
      Automatic segmentation of the ventricular system from MR images of the human brain

      NEUROIMAGE
    2. Ramsey, NF; Sommer, IEC; Rutten, GJ; Kahn, RS
      Combined analysis of language tasks in fMRI improves assessment of hemispheric dominance for language functions in individual subjects

      NEUROIMAGE
    3. Schnack, HG; Pol, HEH; Baare, WFC; Staal, WG; Viergever, MA; Kahn, RS
      Automated separation of gray and white matter from MR images of the human brain

      NEUROIMAGE
    4. Baare, WFC; Pol, HEH; Boomsma, DI; Posthuma, D; de Geus, EJC; Schnack, HG; van Haren, NEM; van Oel, CJ; Kahn, RS
      Quantitative genetic modeling of variation in human brain morphology

      CEREBRAL CORTEX
    5. Aleman, A; Kahn, RS
      Effects of the atypical antipsychotic risperidone on hostility and aggression in schizophrenia: a meta-analysis of controlled trials

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    6. van Oel, CJ; Baare, WFC; Pol, HEH; Haag, J; Balazs, J; Dingemans, A; Kahn, RS; Sitskoorn, MM
      Differentiating between low and high susceptibility to schizophrenia in twins: the significance of dermatoglyphic indices in relation to other determinants of brain development

      SCHIZOPHRENIA RESEARCH
    7. Sommer, IEC; Ramsey, NF; Kahn, RS
      Language lateralization in schizophrenia, an fMRI study

      SCHIZOPHRENIA RESEARCH
    8. Jansma, JM; Ramsey, NF; Slagter, HA; Kahn, RS
      Functional anatomical correlates of controlled and automatic processing

      JOURNAL OF COGNITIVE NEUROSCIENCE
    9. Scheepers, FE; Wied, CCG; Westenberg, HGM; Kahn, RS
      The effect of olanzapine treatment on monoamine metabolite concentrations in the cerebrospinal fluid of schizophrenic patients

      NEUROPSYCHOPHARMACOLOGY
    10. Scheepers, FE; de Wied, CCG; Pol, HEH; van de Flier, W; van der Linden, JA; Kahn, RS
      The effect of clozapine on caudate nucleus volume in schizophrenic patients previously treated with typical antipsychotics

      NEUROPSYCHOPHARMACOLOGY
    11. Lampe, IK; Kahn, RS; Heeren, TJ
      Apathy, anhedonia, and psychomotor retardation in elderly psychiatric patients and healthy elderly individuals

      JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY
    12. Scheepers, FE; de Wied, CCG; Kahn, RS
      The effect of olanzapine treatment on m-chlorophenylpiperazine-induced hormone release in schizophrenia

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    13. Lanphear, BP; Kahn, RS; Berger, O; Auinger, P; Bortnick, SM; Nahhas, RW
      Contribution of residential exposures to asthma in US children and adolescents

      PEDIATRICS
    14. Pol, HEH; Schnack, HG; Mandl, RCW; van Haren, NEM; Koning, H; Collins, DL; Evans, AC; Kahn, RS
      Focal gray matter density changes in schizophrenia

      ARCHIVES OF GENERAL PSYCHIATRY
    15. Baare, WFC; van Oel, CJ; Pol, HEH; Schnack, HG; Durston, S; Sitskoorn, MM; Kahn, RS
      Volumes of brain structures in twins discordant for schizophrenia

      ARCHIVES OF GENERAL PSYCHIATRY
    16. Staal, WG; Pol, HEH; Schnack, HG; van Haren, NEM; Seifert, N; Kahn, RS
      Structural brain abnormalities in chronic schizophrenia at the extremes ofthe outcome spectrum

      AMERICAN JOURNAL OF PSYCHIATRY
    17. Scheepers, FE; de Wied, CCG; Pol, HEH; Kahn, RS
      Effect of clozapine on caudate nucleus volume in relation to symptoms of schizophrenia

      AMERICAN JOURNAL OF PSYCHIATRY
    18. Kossen, M; Selten, JP; Kahn, RS
      Elevated clozapine plasma level with lamotrigine

      AMERICAN JOURNAL OF PSYCHIATRY
    19. Jansma, JM; Ramsey, NF; Coppola, R; Kahn, RS
      Specific versus nonspecific brain activity in a parametric n-back task

      NEUROIMAGE
    20. Kahn, RS; Wise, PH; Kennedy, BP; Kawachi, I
      State income inequality, household income, and maternal mental and physical health: cross sectional national survey

      BRITISH MEDICAL JOURNAL
    21. Pol, HEH; van der Flier, WM; Schnack, HG; Tulleken, CAF; Ramos, LM; van Ree, JM; Kahn, RS
      Frontal lobe damage and thalamic volume changes

      NEUROREPORT
    22. Oranje, B; van Berckel, BNM; Kemmer, C; van Ree, JM; Kahn, RS; Verbaten, MN
      The effects of a sub-anaesthetic dose of ketamine on human selective attention

      NEUROPSYCHOPHARMACOLOGY
    23. Staal, WG; Hijman, R; Pol, HEH; Kahn, RS
      Neuropsychological dysfunctions in siblings discordant for schizophrenia

      PSYCHIATRY RESEARCH
    24. Bocker, KBE; Hijman, R; Kahn, RS; De Haan, EHF
      Perception, mental imagery and reality discrimination in hallucinating andnon-hallucinating schizophrenic patients

      BRITISH JOURNAL OF CLINICAL PSYCHOLOGY
    25. Hulshoff, HE; Hoek, HW; Susser, E; Brown, AS; Dingemans, A; Schnack, HG; van Haren, NEM; Ramos, LMP; Gispen-de Wied, CC; Kahn, RS
      Prenatal exposure to famine and brain morphology in schizophrenia

      AMERICAN JOURNAL OF PSYCHIATRY
    26. Staal, WG; Pol, HEH; Schnack, HG; Hoogendoorn, MLC; Jellema, K; Kahn, RS
      Structural brain abnormalities in patients with schizophrenia and their healthy siblings

      AMERICAN JOURNAL OF PSYCHIATRY
    27. Posthuma, D; de Geus, EJC; Neale, MC; Pol, HEH; Baare, WEC; Kahn, RS; Boomsma, D
      Multivariate genetic analysis of brain structure in an extended twin design

      BEHAVIOR GENETICS
    28. Wijkstra, J; Nolen, WA; Algra, A; van Vliet, IM; Kahn, RS
      Relapse prevention in major depressive disorder after successful ECT: a literature review and a naturalistic case series

      ACTA PSYCHIATRICA SCANDINAVICA
    29. Jansen, LMC; Gispen-de Wied, CC; Kahn, RS
      Selective impairments in the stress response in schizophrenic patients

      PSYCHOPHARMACOLOGY
    30. van Harten, PN; Hoek, HW; Kahn, RS
      Fortnightly review - Acute dystonia induced by drug treatment

      BRITISH MEDICAL JOURNAL
    31. Selten, JP; Brown, AS; Moons, KGM; Slaets, JPJ; Susser, ES; Kahn, RS
      Prenatal exposure to the 1957 influenza pandemic and non-affective psychosis in The Netherlands

      SCHIZOPHRENIA RESEARCH
    32. Selten, JP; van der Graaf, Y; van Duursen, R; Gispen-de Wied, CC; Kahn, RS
      Psychotic illness after prenatal exposure to the 1953 Dutch Flood Disaster

      SCHIZOPHRENIA RESEARCH
    33. van Berckel, BNM; Evenblij, CN; van Loon, BJAM; Maas, MF; van der Geld, MAM; Wynne, HJ; van Ree, JM; Kahn, RS
      D-cycloserine increases positive symptoms in chronic schizophrenic patients when administered in addition to antipsychotics: A double-blind, parallel, placebo-controlled study

      NEUROPSYCHOPHARMACOLOGY
    34. van Harten, PN; Kahn, RS
      Tardive dystonia

      SCHIZOPHRENIA BULLETIN
    35. Staal, WG; Pol, HEH; Kahn, RS
      Outcome of schizophrenia in relation to brain abnormalities

      SCHIZOPHRENIA BULLETIN
    36. Schiff, ER; De Medina, M; Kahn, RS
      New perspectives in the diagnosis of hepatitis C

      SEMINARS IN LIVER DISEASE
    37. Sommer, IEC; Ramsey, NF; Bouma, A; Kahn, RS
      Cerebral mirror-imaging in a monozygotic twin

      LANCET
    38. Kahn, RS; Wise, PH; Finkelstein, JA; Bernstein, HH; Lowe, JA; Homer, CJ
      The scope of unmet maternal health needs in pediatric settings

      PEDIATRICS
    39. Oranje, B; van Berckel, BNM; Kemner, C; van Ree, JM; Kahn, RS; Verbaten, MN
      P50 suppression and prepulse inhibition of the startle reflex in humans: Acorrelational study

      BIOLOGICAL PSYCHIATRY
    40. Baare, WFC; Pol, HEH; Hijman, R; Mali, WPT; Viergever, MA; Kahn, RS
      Volumetric analysis of frontal lobe regions in schizophrenia: Relation to cognitive function and symptomatology

      BIOLOGICAL PSYCHIATRY
    41. Aleman, A; Hijman, R; de Haan, EHF; Kahn, RS
      Memory impairment in schizophrenia: A meta-analysis

      AMERICAN JOURNAL OF PSYCHIATRY
    42. van Harten, PN; Hoek, HW; Matroos, GE; Koeter, M; Kahn, RS
      Neuroleptic discontinuation and tardive dyskinesia risk - Dr. van Harten and colleagues reply

      AMERICAN JOURNAL OF PSYCHIATRY
    43. Schouten, EAM; D'Alfonso, AAL; Nolen, WA; De Haan, EHF; Wijkstra, J; Kahn, RS
      Mood improvement from transcranial magnetic stimulation

      AMERICAN JOURNAL OF PSYCHIATRY
    44. RAMSEY NF; VANDENBRINK JS; VANMUISWINKEL AMC; FOLKERS PJM; MOONEN CTW; JANSMA JM; KAHN RS
      PHASE NAVIGATOR CORRECTION IN 3D FMRI IMPROVES DETECTION OF BRAIN ACTIVATION - QUANTITATIVE ASSESSMENT WITH A GRADED MOTOR ACTIVATION PROCEDURE

      NeuroImage (Orlando, Fla. Print)
    45. JANSMA JM; RAMSEY NF; KAHN RS
      TACTILE STIMULATION DURING FINGER OPPOSITION DOES NOT CONTRIBUTE TO 3D FMRI BRAIN ACTIVITY PATTERN

      NeuroReport
    46. JANSEN LMC; GISPENDEWIED CC; GADEMAN PJ; DEJONGE RCJ; VANDERLINDEN JA; KAHN RS
      BLUNTED CORTISOL RESPONSE TO A PSYCHOSOCIAL STRESSOR IN SCHIZOPHRENIA

      Schizophrenia research
    47. SELTEN JP; BROWN AS; SLAETS JPJ; SUSSER E; KAHN RS
      PRENATAL EXPOSURE TO 1957 INFLUENZA PANDEMIC AND NONAFFECTIVE PSYCHOSIS IN THE NETHERLANDS

      Schizophrenia research
    48. SELTEN JP; VANLOON AM; VANVLIET K; PLEYTE W; HOEK HW; KAHN RS
      BORNA-DISEASE VIRUS IN CARIBBEAN IMMIGRANTS TO THE NETHERLANDS, DIAGNOSED WITH SCHIZOPHRENIA

      Schizophrenia research
    49. HIJMAN R; BAARE WFC; VANHAREN N; PRONK S; VANDERLINDEN J; KAHN RS
      EXTERNALLY ORDERED AND SELF-ORDERING WORKING-MEMORY TASKS IN SCHIZOPHRENIA

      Schizophrenia research
    50. HIJMAN R; POL HEH; GISPENDEWIED CC; VANOEL C; CAHN W; VANDERLINDEN J; KAHN RS
      VERBAL AND VISUAL MEMORY DEFICITS IN SCHIZOPHRENIA

      Schizophrenia research
    51. POL HEH; GISPENDEWIED CC; RAMOS LM; VANDERLINDEN J; CAHN W; SELTEN JP; VANOEL C; BAARE WFC; STAAL WG; MALI WPTM; KAHN RS
      NO INCREASE IN ABNORMALITIES IN THE CLINICAL NEURORADIOLOGICAL EXAM IN SCHIZOPHRENIA

      Schizophrenia research
    52. RAMSEY NF; JANSMA JMJ; CAHN W; MALI WPTM; KAHN RS
      MOTION-CORRECTED 3D FMRI ASSESSMENT OF VISUAL-CORTEX - SCHIZOPHRENIC-PATIENTS SHOW THE SAME REGIONAL RESPONSE TO PHOTIC-STIMULATION AS CONTROLS

      Schizophrenia research
    53. JANSMA JM; RAMSEY NF; VANDERLINDEN JA; KAHN RS
      SCHIZOPHRENIC-PATIENTS EXHIBIT INCREASED SENSORIMOTOR CORTEX ACTIVATION WITH EQUAL PERFORMANCE-LEVEL

      Schizophrenia research
    54. STAAL WG; POL HEH; SCHNACK HG; VANDERSCHOT A; GISPENDEWIED CC; HIJMAN R; KAHN RS
      THALAMIC VOLUMES IN PATIENTS WITH SCHIZOPHRENIA, HEALTHY SIBLINGS ANDNORMAL CONTROLS

      Schizophrenia research
    55. AMIN F; STROE AE; KAHN T; KNOTT PJ; KAHN RS; DAVIDSON M
      CONTROL OF RENAL FACTORS IN PLASMA HOMOVANILLIC-ACID MEASUREMENTS

      Neuropsychopharmacology
    56. HANDELSMAN L; KAHN RS; STURIANO C; RINALDI PJ; GABRIEL S; SCHMEIDLER JP; BERNSTEIN DP; SIEVER L; COOPER TB
      HOSTILITY IS ASSOCIATED WITH A HEIGHTENED PROLACTIN RESPONSE TO META-CHLOROPHENYLPIPERAZINE IN ABSTINENT COCAINE ADDICTS

      Psychiatry research
    57. VANHARTEN PN; HOEK HW; MATROOS GE; KOETER M; KAHN RS
      INTERMITTENT NEUROLEPTIC TREATMENT AND RISK FOR TARDIVE-DYSKINESIA - CURACAO EXTRAPYRAMIDAL SYNDROMES STUDY III

      The American journal of psychiatry
    58. Staal, WG; Hulshoff, HE; Schnack, H; van der Schot, AC; Kahn, RS
      Partial volume decrease of the thalamus in relatives of patients with schizophrenia

      AMERICAN JOURNAL OF PSYCHIATRY
    59. VANBERCKEL BNM; LIPSCH C; GISPENDEWIED C; WYNNE HJ; BLANKENSTEIN MA; VANREE JM; KAHN RS
      THE PARTIAL NMDA AGONIST D-CYCLOSERINE STIMULATES LH-SECRETION IN HEALTHY-VOLUNTEERS

      Psychopharmacology
    60. VANBERCKEL BNM; ORANJE B; VANREE JM; VERBATEN MN; KAHN RS
      THE EFFECTS OF LOW-DOSE KETAMINE ON SENSORY GATING, NEUROENDOCRINE SECRETION AND BEHAVIOR IN HEALTHY-HUMAN SUBJECTS

      Psychopharmacology
    61. VANHARTEN PN; HOEK HW; MATROOS GE; KOETER M; KAHN RS
      THE INTERRELATIONSHIPS OF TARDIVE-DYSKINESIA, PARKINSONISM, AKATHISIAAND TARDIVE DYSTONIA - THE CURACAO EXTRAPYRAMIDAL SYNDROMES STUDY .2.

      Schizophrenia research
    62. GISPENDEWIED CC; JANSEN LMC; VANDERLINDEN JA; KAHN RS
      CORTISOL RESPONSE TO A PSYCHOSOCIAL STRESSOR IN SCHIZOPHRENIA

      Schizophrenia research
    63. KROMKAMP M; BAARE WFC; POL HEH; VANDERLINDEN JA; KAHN RS
      REDUCTION OF NUCLEUS-ACCUMBENS VOLUME IN SCHIZOPHRENIA - A VOLUMETRICMRI-STUDY

      Schizophrenia research
    64. SCHNACK HG; POL HEH; STAAL W; VINCKEN K; NIESSEN WM; VIERGEVER MA; KAHN RS
      APPLICATION OF A NEARLY AUTOMATIC IMAGE SCALE-SPACE LINKING SCHEME TOSEGMENT GRAY AND WHITE-MATTER AND INTRACRANIAL VOLUMES ON MR-IMAGES

      Schizophrenia research
    65. VANBERCKEL BNM; LIPSCH C; GISPENDEWIED C; WYNNE HJ; BLANKENSTEIN RA; VANREE JM; KAHN RS
      THE PARTIAL NMDA AGONIST D-CYCLOSERINE STIMULATES LH-SECRETION IN HEALTHY-VOLUNTEERS

      Schizophrenia research
    66. SELTEN JP; DIJKGRAAF M; VANDERGRAAF Y; KAHN RS
      SEASONALITY OF BIRTH IN SCHIZOPHRENIA AND MAJOR AFFECTIVE-ILLNESS IN THE NETHERLANDS

      Schizophrenia research
    67. SELTEN JP; VANDUURSEN R; VANDERGRAAF Y; GISPENDEWIED C; KAHN RS
      2ND-TRIMESTER EXPOSURE TO MATERNAL STRESS IS A POSSIBLE RISK FACTOR FOR PSYCHOTIC ILLNESS IN THE CHILD

      Schizophrenia research
    68. VANBERCKEL BNM; LIPSCH C; TIMP S; DEWIED CG; WYNNE H; VANREE JM; KAHN RS
      BEHAVIORAL AND NEUROENDOCRINE EFFECTS OF THE PARTIAL NMDA AGONIST D-CYCLOSERINE IN HEALTHY-SUBJECTS

      Neuropsychopharmacology
    69. VANOEL CJ; KAHN RS
      BIRTH-ORDER AND LOW-BIRTH-WEIGHT AS PREDICTORS FOR SCHIZOPHRENIA IN DISCORDANT TWINS

      American journal of medical genetics
    70. SELTEN JP; SLAETS JPJ; KAHN RS
      SCHIZOPHRENIA IN SURINAMESE AND DUTCH ANTILLEAN IMMIGRANTS TO THE NETHERLANDS - EVIDENCE OF AN INCREASED INCIDENCE

      Psychological medicine
    71. VANMEGEN HJGM; WESTENBERG HGM; DENBOER JA; KAHN RS
      CHOLECYSTOKININ IN ANXIETY

      European neuropsychopharmacology
    72. VANMEGEN HJGM; WESTENBERG HGM; DENBOER JA; KAHN RS
      THE PANIC-INDUCING PROPERTIES OF THE CHOLECYSTOKININ TETRAPEPTIDE CCK4 IN PATIENTS WITH PANIC DISORDER

      European neuropsychopharmacology
    73. HIJMAN R; POL HEH; BAARE WFC; TALMA H; VANDERLINDEN J; KAHN RS
      RETENTION IN SCHIZOPHRENIA-PATIENTS ON 2 WORKING-MEMORY TASKS

      Schizophrenia research
    74. BAARE WFC; POL HEH; HIJMAN R; KAHN RS
      VOLUMES OF FRONTAL-LOBE SUBREGIONS IN SCHIZOPHRENIA - RELATION TO COGNITIVE FUNCTION AND CLINICAL SYMPTOMATOLOGY

      Schizophrenia research
    75. VANBERCKEL BNM; HIJMAN R; VANDERLINDEN JA; WESTENBERG HGM; VANREE JM; KAHN RS
      TOLERANCE AND EFFICACY OF D-CYCLOSERINE IN DRUG-FREE SCHIZOPHRENIC-PATIENTS

      Schizophrenia research
    76. POL HEH; HIJMAN R; MEYER P; TULLEKEN CAF; RAMOS LMP; VIERGEVER MA; KAHN RS; VANREE JM
      IMPROVEMENT OF MEMORY IN PATIENTS FOLLOWING FRONTAL-LOBE DAMAGE - A LONGITUDINAL FOLLOW-UP-STUDY USING 3D MR-IMAGING

      Schizophrenia research
    77. HANDELSMAN L; HOLLOWAY K; KAHN RS; STURIANO C; RINALDI PJ; BERNSTEIN DP; SIEVER L; GABRIEL S; COOPER TB
      HOSTILITY IS ASSOCIATED WITH A LOW PROLACTIN RESPONSE TO META-CHLOROPHENYLPIPERAZINE IN ABSTINENT ALCOHOLICS

      Alcoholism, clinical and experimental research
    78. VANBERCKEL BNM; HIJMAN R; VANDERLINDEN JA; WESTENBERG HGM; VANREE JM; KAHN RS
      EFFICACY AND TOLERANCE OF D-CYCLOSERINE IN DRUG-FREE SCHIZOPHRENIC-PATIENTS

      Biological psychiatry
    79. HIJMAN R; POL HEH; BAARE WFC; VANDERLINDEN J; KAHN RS
      SHORT-TERM RETENTION AND WORKING-MEMORY IN SCHIZOPHRENIA

      Schizophrenia research
    80. POL HEH; HIJMAN R; TULLEKEN CAF; RAMOS LM; KAHN RS; VANREE JM
      DAMAGE TO SUBREGIONS OF THE FRONTAL-LOBE DIFFERENTIALLY INFLUENCES MEMORY FUNCTIONING

      Schizophrenia research
    81. AMIN F; DAVIDSON M; KAHN RS; SCHMEIDLER J; STERN R; KNOTT PJ; APTER S
      ASSESSMENT OF THE CENTRAL DOPAMINERGIC INDEX OF PLASMA HVA IN SCHIZOPHRENIA

      Schizophrenia bulletin
    82. KAHN RS; HARVEY PD; DAVIDSON M; KEEFE RSE; APTER S; NEALE JM; MOHS RC; DAVIS KL
      NEUROPSYCHOLOGICAL CORRELATES OF CENTRAL MONOAMINE FUNCTION IN CHRONIC-SCHIZOPHRENIA - RELATIONSHIP BETWEEN CSF METABOLITES AND COGNITIVE FUNCTION

      Schizophrenia research
    83. KAHN RS
      SEROTONIN FUNCTION AND CLOZAPINE IN SCHIZOPHRENIA

      Schizophrenia research
    84. STERN RG; KAHN RS; HARVEY PD; DAVIDSON M
      PREDICTORS OF RESPONSE HALOPERIDOL OR TO CLOZAPINE OR OF FAILURE TO BOTH

      Schizophrenia research
    85. EPSTEIN JI; KAHN RS; MACALUSO JM; SEVY S; HIRSHOWITZ J; DAVIDSON M
      DOPAMINE AGONIST TREATMENT IN SCHIZOPHRENIA

      Schizophrenia research
    86. POL HEH; TULLEKEN CAF; HIJMAN R; VIERGEVER MA; KAHN RS; VANREE JM
      3-DIMENSIONAL RECONSTRUCTION OF THE FRONTAL LOBES

      Schizophrenia research
    87. PERRIN JM; KAHN RS; BLOOM SR; DAVIDSON S; GUYER B; HOLLINSHEAD W; RICHMOND JB; WALKER DK; WISE PH
      HEALTH-CARE REFORM AND THE SPECIAL NEEDS OF CHILDREN

      Pediatrics
    88. KAHN RS
      CHALLENGE TESTS IN PANIC DISORDER FOR NA AND 5HT

      Biological psychiatry
    89. KAHN RS; DAVIDSON M; SIEVER LJ; SEVY S; DAVIS KL
      CLOZAPINE TREATMENT AND ITS EFFECT ON NEUROENDOCRINE RESPONSES INDUCED BY THE SEROTONIN AGONIST, M-CHLOROPHENYLPIPERAZINE

      Biological psychiatry
    90. STERN RG; KAHN RS; DAVIDSON M; NORA RM; DAVIS KL
      EARLY RESPONSE TO CLOZAPINE IN SCHIZOPHRENIA

      The American journal of psychiatry
    91. KAHN RS; TRESTMAN R; LAWLOR BA; GABRIEL S; DAVIDSON M; SIEVER L
      EFFECTS OF IPSAPIRONE IN HEALTHY-SUBJECTS - A DOSE-RESPONSE STUDY

      Psychopharmacology
    92. STERN RG; KAHN RS; HARVEY PD; AMIN F; APTER SH; HIRSCHOWITZ J
      EARLY RESPONSE TO HALOPERIDOL TREATMENT IN CHRONIC-SCHIZOPHRENIA

      Schizophrenia research
    93. KAHN RS; DAVIDSON M
      SEROTONIN RECEPTOR RESPONSIVITY IN SCHIZOPHRENIA

      International clinical psychopharmacology
    94. STERN RG; KAHN RS; DAVIDSON M
      PREDICTORS OF RESPONSE TO NEUROLEPTIC TREATMENT IN SCHIZOPHRENIA

      The Psychiatric clinics of North America
    95. GALYNKER I; KAHN RS
      SLOW EATING - OCD OR SIMPLE PHOBIA - REPLY

      The Journal of clinical psychiatry
    96. GREENWALD C; KAHN RS; DAVIDSON M; SIEVER L; DAVIS KL
      MONOAMINE FUNCTION AND RESPONSE TO CLOZAPINE IN SCHIZOPHRENIA

      Biological psychiatry
    97. GREENWALD C; KAHN RS; STERN RG; DAVIDSON M; DAVIS KL
      RELATIONSHIPS BETWEEN HVA CONCENTRATIONS MEASURED IN CSF AND PLASMA

      Biological psychiatry
    98. KAHN RS; DAVIDSON M; KNOTT P; STERN RG; APTER S; DAVIS KL
      EFFECT OF NEUROLEPTIC MEDICATION ON CEREBROSPINAL-FLUID MONOAMINE METABOLITE CONCENTRATIONS IN SCHIZOPHRENIA - SEROTONIN-DOPAMINE INTERACTIONS AS A TARGET FOR TREATMENT

      Archives of general psychiatry
    99. KAHN RS; DAVIDSON M; SIEVER L; GABRIEL S; APTER S; DAVIS KL
      SEROTONIN FUNCTION AND TREATMENT RESPONSE TO CLOZAPINE IN SCHIZOPHRENIC-PATIENTS

      The American journal of psychiatry
    100. KAHN RS; DAVIDSON M
      SEROTONIN, DOPAMINE AND THEIR INTERACTIONS IN SCHIZOPHRENIA - AN EDITORIAL

      Psychopharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 09/12/19 alle ore 04:08:13